{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:21:31Z","timestamp":1788790891944,"version":"build-2803163510"},"reference-count":70,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F32DK128970"],"award-info":[{"award-number":["F32DK128970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hypothalamic obesity (HO) is defined as abnormal weight gain due to physical destruction of the hypothalamus. Suprasellar tumors, most commonly craniopharyngiomas, are a classic cause of HO. HO often goes unnoticed initially as patients, families, and medical teams are focused on oncologic treatments and management of panhypopituitarism. HO is characterized by rapid weight gain in the first year after hypothalamic destruction followed by refractory obesity due to an energy imbalance of decreased energy expenditure without decreased food intake. Currently available pharmacotherapies are less effective in HO than in common obesity. While not a cure, dietary interventions, pharmacotherapy, and bariatric surgery can mitigate the effects of HO. Early recognition of HO is necessary to give an opportunity to intervene before substantial weight gain occurs. Our goal for this article is to review the pathophysiology of HO and to discuss available treatment options and future directions for prevention and treatment.<\/jats:p>","DOI":"10.1210\/clinem\/dgac678","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T17:55:50Z","timestamp":1669139750000},"page":"1236-1242","source":"Crossref","is-referenced-by-count":24,"title":["Approach to the Patient With Hypothalamic Obesity"],"prefix":"10.1210","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1628-3677","authenticated-orcid":false,"given":"Ashley H","family":"Shoemaker","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology, Vanderbilt University Medical Center , Nashville, TN 37212 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Tamaroff","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology, Vanderbilt University Medical Center , Nashville, TN 37212 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"issue":"4","key":"2023062815352426700_dgac678-B1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2001-16855","article-title":"Obesity after childhood craniopharyngioma\u2014German multicenter study on pre-operative risk factors and quality of life","volume":"213","author":"M\u00fcller","year":"2001","journal-title":"Klin Padiatr"},{"issue":"1","key":"2023062815352426700_dgac678-B2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/EJE-11-0158","article-title":"Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up","volume":"165","author":"M\u00fcller","year":"2011","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023062815352426700_dgac678-B3","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/oby.21067","article-title":"Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity","volume":"23","author":"Roth","year":"2015","journal-title":"Obesity (Silver Spring)"},{"issue":"6","key":"2023062815352426700_dgac678-B4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-2004-832339","article-title":"Prognosis and sequela in patients with childhood craniopharyngioma\u2014results of HIT-ENDO and update on KRANIOPHARYNGEOM 2000","volume":"216","author":"M\u00fcller","year":"2004","journal-title":"Klin Padiatr"},{"issue":"3","key":"2023062815352426700_dgac678-B5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2265.2009.03639.x","article-title":"Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma","volume":"72","author":"Simoneau-Roy","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2023062815352426700_dgac678-B6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-022-00351-z","article-title":"Hypothalamic syndrome","volume":"8","author":"M\u00fcller","year":"2022","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"2023062815352426700_dgac678-B7","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1210\/jc.2002-021797","article-title":"Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity","volume":"88","author":"Harz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023062815352426700_dgac678-B8","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41366-021-01043-6","article-title":"Energy balance in hypothalamic obesity in response to treatment with a once-weekly GLP-1 receptor agonist","volume":"46","author":"Shoemaker","year":"2022","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"2023062815352426700_dgac678-B9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/oby.21493","article-title":"A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity","volume":"24","author":"Lomenick","year":"2016","journal-title":"Obesity (Silver Spring)"},{"issue":"8","key":"2023062815352426700_dgac678-B10","doi-asserted-by":"crossref","first-page":"e220276","DOI":"10.1530\/EC-22-0276","article-title":"Resting energy expenditure in children at risk of hypothalamic dysfunction","volume":"11","author":"Van Schaik","year":"2022","journal-title":"Endocr Connect"},{"issue":"8","key":"2023062815352426700_dgac678-B11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrendo.2015.103","article-title":"Cognitive and autonomic determinants of energy homeostasis in obesity","volume":"11","author":"Richard","year":"2015","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"2023062815352426700_dgac678-B12","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/oby.2007.216","article-title":"Assessment of hyperphagia in Prader-Willi syndrome","volume":"15","author":"Dykens","year":"2007","journal-title":"Obesity"},{"issue":"1","key":"2023062815352426700_dgac678-B13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.radonc.2005.04.015","article-title":"Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma","volume":"77","author":"Pemberton","year":"2005","journal-title":"Radiother Oncol"},{"issue":"4","key":"2023062815352426700_dgac678-B14","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0360-3016(92)90705-M","article-title":"Pediatric craniopharyngiomas: long term results of combined treatment with surgery and radiation","volume":"24","author":"Regine","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2023062815352426700_dgac678-B15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0360-3016(03)01570-0","article-title":"Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults","volume":"58","author":"Stripp","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8-9","key":"2023062815352426700_dgac678-B16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00381-005-1202-9","article-title":"Craniopharyngiomas in children: surgical experience at Children's Memorial Hospital","volume":"21","author":"Tomita","year":"2005","journal-title":"Childs Nerv Syst"},{"issue":"1","key":"2023062815352426700_dgac678-B17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12020-022-03134-4","article-title":"Long-term outcomes in patients with adult-onset craniopharyngioma","volume":"78","author":"Dogra","year":"2022","journal-title":"Endocrine"},{"issue":"2","key":"2023062815352426700_dgac678-B18","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3171\/PED\/2008\/1\/2\/126","article-title":"Long-term outcome in children treated for craniopharyngioma with and without radiotherapy","volume":"1","author":"Lin","year":"2008","journal-title":"J Neurosurg Pediatr"},{"issue":"10","key":"2023062815352426700_dgac678-B19","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1007\/s00381-022-05635-z","article-title":"Upfront adjuvant irradiation versus postoperative surveillance following incomplete surgical resection of craniopharyngiomas in children and young adults","volume":"38","author":"Sarkar","year":"2022","journal-title":"Childs Nerv Syst"},{"key":"2023062815352426700_dgac678-B20","author":"Gourash"},{"issue":"1","key":"2023062815352426700_dgac678-B21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1542\/peds.2010-2820","article-title":"Clinical report-health supervision for children with Prader-Willi syndrome","volume":"127","author":"McCandless","year":"2011","journal-title":"Pediatrics"},{"issue":"7","key":"2023062815352426700_dgac678-B22","doi-asserted-by":"crossref","first-page":"e12903","DOI":"10.1111\/ijpo.12903","article-title":"Novel clinical algorithm for hypothalamic obesity in youth with brain tumours and factors associated with excess weight gain","volume":"17","author":"Rydin","year":"2022","journal-title":"Pediatr Obes"},{"issue":"7","key":"2023062815352426700_dgac678-B23","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/oby.23447","article-title":"Postoperative hypothalamic damage predicts postoperative weight gain in patients with adult-onset craniopharyngioma","volume":"30","author":"Wu","year":"2022","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"2023062815352426700_dgac678-B24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000496564","article-title":"Hypothalamic obesity: prologue and promise","volume":"91","author":"Abuzzahab","year":"2019","journal-title":"Horm Res Paediat"},{"issue":"2","key":"2023062815352426700_dgac678-B25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/dom.14224","article-title":"A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity","volume":"23","author":"Roth","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2023062815352426700_dgac678-B26","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-21-0972","article-title":"Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity","volume":"186","author":"Huynh","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2023062815352426700_dgac678-B27","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/dom.12928","article-title":"A randomized, placebo-controlled trial of beloranib for the treatment of hypothalamic injury-associated obesity","volume":"19","author":"Shoemaker","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"2023062815352426700_dgac678-B28","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1210\/jc.2002-030003","article-title":"Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial","volume":"88","author":"Lustig","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023062815352426700_dgac678-B29","first-page":"R686","article-title":"Macronutrient self-selection in three forms of hypothalamic obesity","volume":"244","author":"Sclafani","year":"1983","journal-title":"Am J Physiol"},{"issue":"8275","key":"2023062815352426700_dgac678-B30","doi-asserted-by":"crossref","first-page":"m4743","DOI":"10.1136\/bmj.m4743","article-title":"Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data","volume":"372","author":"Goldenberg","year":"2021","journal-title":"BMJ"},{"issue":"11","key":"2023062815352426700_dgac678-B31","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1053\/meta.2002.35591","article-title":"Triiodothyronine supplementation for hypothalamic obesity","volume":"51","author":"Fernandes","year":"2002","journal-title":"Metabolism"},{"issue":"1-2","key":"2023062815352426700_dgac678-B32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1515\/jpem-2014-0337","article-title":"Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity","volume":"28","author":"van Santen","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"11","key":"2023062815352426700_dgac678-B33","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2023062815352426700_dgac678-B34","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1530\/EJE-17-0154","article-title":"Management of endocrine disease: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects","volume":"177","author":"Mazziotti","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2023062815352426700_dgac678-B35","doi-asserted-by":"crossref","first-page":"7154907","DOI":"10.1155\/2022\/7154907","article-title":"Metabolic effects of recombinant human growth hormone replacement therapy on juvenile patients after craniopharyngioma resection","volume":"2022","author":"Li","year":"2022","journal-title":"Int J Endocrinol"},{"issue":"8","key":"2023062815352426700_dgac678-B36","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1210\/jc.2018-01205","article-title":"GH therapy in childhood cancer survivors: a systematic review and meta-analysis","volume":"103","author":"Tamhane","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2023062815352426700_dgac678-B37","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"5","key":"2023062815352426700_dgac678-B38","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.2014.56.7933","article-title":"Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study","volume":"33","author":"Chemaitilly","year":"2015","journal-title":"J Clin Oncol"},{"issue":"4","key":"2023062815352426700_dgac678-B39","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ecl.2012.07.002","article-title":"Safety of growth hormone treatment in patients previously treated for cancer","volume":"41","author":"Chemaitilly","year":"2012","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"2","key":"2023062815352426700_dgac678-B40","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2023062815352426700_dgac678-B41","doi-asserted-by":"crossref","first-page":"P35","DOI":"10.1530\/EJE-21-1186","article-title":"Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement","volume":"186","author":"Boguszewski","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"2 Pt 1","key":"2023062815352426700_dgac678-B42","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0022-3476(99)70017-X","article-title":"Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist","volume":"135","author":"Lustig","year":"1999","journal-title":"J Pediatr"},{"issue":"8","key":"2023062815352426700_dgac678-B43","first-page":"408","article-title":"Comparing the cost of treatment with octreotide long-acting release versus lanreotide in patients with metastatic gastrointestinal neuroendocrine tumors","volume":"10","author":"Ayyagari","year":"2017","journal-title":"Am Health Drug Benefits"},{"issue":"1","key":"2023062815352426700_dgac678-B44","doi-asserted-by":"crossref","first-page":"417949","DOI":"10.1155\/2011\/417949","article-title":"Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy","volume":"2011","author":"Hamilton","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"issue":"12","key":"2023062815352426700_dgac678-B45","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1210\/jc.2016-2126","article-title":"Diazoxide in children with obesity after hypothalamic-pituitary lesions: a randomized, placebo-controlled trial","volume":"101","author":"Brauner","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"2023062815352426700_dgac678-B46","first-page":"531","article-title":"Multidisciplinary approach for hypothalamic obesity in children and adolescents: a preliminary study","volume":"8","author":"Tessaris","year":"2021","journal-title":"Children (Basel)"},{"issue":"4","key":"2023062815352426700_dgac678-B47","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"issue":"10295","key":"2023062815352426700_dgac678-B48","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"2023062815352426700_dgac678-B49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"2023062815352426700_dgac678-B50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"2023062815352426700_dgac678-B51","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1210\/jc.2013-2000","article-title":"Hypothalamic involvement predicts cognitive performance and psychosocial health in long-term survivors of childhood craniopharyngioma","volume":"98","author":"Fjalldal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2023062815352426700_dgac678-B52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-017-2492-y","article-title":"Neurocognitive functioning in pediatric craniopharyngioma: performance before treatment with proton therapy","volume":"134","author":"Fournier-Goodnight","year":"2017","journal-title":"J Neurooncol"},{"issue":"2","key":"2023062815352426700_dgac678-B53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1515\/JPEM.2006.19.2.129","article-title":"Dexamphetamine use for management of obesity and hypersomnolence following hypothalamic injury","volume":"19","author":"Ismail","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"9","key":"2023062815352426700_dgac678-B54","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/archpedi.156.9.887","article-title":"The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma","volume":"156","author":"Mason","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2023062815352426700_dgac678-B55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fendo.2011.00078","article-title":"Effects of methylphenidate on weight gain and food intake in hypothalamic obesity","volume":"2","author":"Elfers","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2023062815352426700_dgac678-B56","doi-asserted-by":"crossref","first-page":"e28379","DOI":"10.1002\/pbc.28379","article-title":"Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity","volume":"67","author":"Horne","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"2023062815352426700_dgac678-B57","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200014","article-title":"Phentermine\/topiramate for the treatment of adolescent obesity","volume":"1","author":"Kelly","year":"2022","journal-title":"NEJM Evidence"},{"issue":"6","key":"2023062815352426700_dgac678-B58","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP.14.6.697","article-title":"Treatment of hypothalamic obesity with caffeine and ephedrine","volume":"14","author":"Greenway","year":"2008","journal-title":"Endocr Pract"},{"issue":"10","key":"2023062815352426700_dgac678-B59","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.peptides.2009.07.012","article-title":"Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL\/6J mice","volume":"30","author":"Kumar","year":"2009","journal-title":"Peptides"},{"issue":"4","key":"2023062815352426700_dgac678-B60","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2009-0037","article-title":"The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology","volume":"31","author":"Tao","year":"2010","journal-title":"Endocr Rev"},{"issue":"3","key":"2023062815352426700_dgac678-B61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cne.10454","article-title":"Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat","volume":"457","author":"Kishi","year":"2003","journal-title":"J Comp Neurol"},{"key":"2023062815352426700_dgac678-B62","volume-title":"European Childhood Obesity Group Congress.","author":"Roth","year":"2022"},{"issue":"10","key":"2023062815352426700_dgac678-B63","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamasurg.2015.1534","article-title":"Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial","volume":"150","author":"Courcoulas","year":"2015","journal-title":"JAMA Surg"},{"issue":"12","key":"2023062815352426700_dgac678-B64","first-page":"1346","article-title":"Clinical Practice Guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures\u20142019 update: cosponsored by American Association of Clinical Endocrinologists\/American College of Endocrinology, the Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists\u2014Executive Summary","volume":"25","author":"Mechanick","year":"2019","journal-title":"Endocr Pract"},{"issue":"7","key":"2023062815352426700_dgac678-B65","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.soard.2018.03.019","article-title":"ASMBS pediatric metabolic and bariatric surgery guidelines, 2018","volume":"14","author":"Pratt","year":"2018","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"2023062815352426700_dgac678-B66","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/er.2018-00017","article-title":"Pathophysiology and individualized treatment of hypothalamic obesity following craniopharyngioma and other suprasellar tumors: a systematic review","volume":"40","author":"van Iersel","year":"2019","journal-title":"Endocr Rev"},{"issue":"2","key":"2023062815352426700_dgac678-B67","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ijo.2016.195","article-title":"Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up","volume":"41","author":"Wijnen","year":"2017","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"2023062815352426700_dgac678-B68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/nyas.13409","article-title":"Mechanisms of weight loss and improved metabolism following bariatric surgery","volume":"1411","author":"Mulla","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2023062815352426700_dgac678-B69","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.2012.04409.x","article-title":"Bariatric surgery for morbid obesity in craniopharyngioma","volume":"78","author":"Weismann","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2023062815352426700_dgac678-B70","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0031-1284420","article-title":"Long-term follow-up of morbidly obese patients with childhood craniopharyngioma after laparoscopic adjustable gastric banding (LAGB)","volume":"223","author":"M\u00fcller","year":"2011","journal-title":"Klin Padiatr"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgac678\/47645705\/dgac678.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/5\/1236\/50731493\/dgac678.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/108\/5\/1236\/50731493\/dgac678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T15:36:23Z","timestamp":1687966583000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/108\/5\/1236\/6840302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":70,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,11,22]]},"published-print":{"date-parts":[[2023,4,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgac678","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5,1]]},"published":{"date-parts":[[2022,11,22]]}}}